The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease

Blood Cancer Journal

Volumn 2, Issue 1, 2012, Pages

  Virtanen, J M ^a   Remes, K J ^a   Itala Remes M A ^a   Saunavaara, J P ^a   Komu, M E ^a   Partanen, A M ^b   Parkkola, R K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cardiac; Iron overload; Liver; Magnetic resonance imaging

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; CALIBRATION; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HUMAN; IRON OVERLOAD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84863887300     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.48     Document Type: Article

References (36)

1. Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981; 304: 319-324. (Pubitemid 11179024)
2. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 331: 574-578. (Pubitemid 24265699)
3. Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008; 22(Suppl 2): S14-S21.
4. Fenaux P, Rose C. Impact of iron overload in myelodysplastic syndromes. Blood Rev 2009; 23(Suppl 1): S15-S19.
5. Malcovati L, Della Porta MG, Cazzola M. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. Haematologica 2006; 91: 1588-1590. (Pubitemid 46032954)
6. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007; 25: 3503-3510. (Pubitemid 47315575)
7. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-768. (Pubitemid 27106467)
8. Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003; 101: 15-19. (Pubitemid 36025881)
9. Nielsen P, Günther U, Dürken M, Fischer R, Düllmann J. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med 2000; 135: 413-418.
10. Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, Irwan R, van der Jagt EJ et al. Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging 2007; 25: 228-231. (Pubitemid 46162057)
11. Wood JC, Enriquez C, Ghugre N, Tyzka MJ, Carson S, Nelson MD et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusiondependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465. (Pubitemid 41129616)
12. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105: 855-861. (Pubitemid 40070775)
13. Alústiza JM, Castiella A, De Juan MD, Emparanza JI, Artetxe J, Uranga M. Iron overload in the liver diagnostic and quantification. Eur J Radiol 2007; 61: 499-506.
14. Virtanen JM, Komu ME, Parkkola RK. Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. Magn Reson Imaging 2008; 26: 1175-1182.
15. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362. (Pubitemid 38169542)
16. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179. (Pubitemid 33139463)
17. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39. (Pubitemid 36791266)
18. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD, Coates TD, Wood JC. MRI detects myocardial iron in the human heart. Magn Reson Med 2006; 56: 681-686. (Pubitemid 44338890)
19. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003; 18: 616-620. (Pubitemid 37345172)
20. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K et al. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005; 21: 531-538. (Pubitemid 41435154)
21. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006; 91: 1388-1391. (Pubitemid 44569814)
22. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004; 103: 1934-1936. (Pubitemid 38268994)
23. Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008; 112: 2973-2978.
24. Konen E, Ghoti H, Goitein O, Winder A, Kushnir T, Eshet Y et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 2007; 82: 1013-1016. (Pubitemid 350004394)
25. Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol 2007; 138: 587-593. (Pubitemid 47206717)
26. Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V. The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. J Cardiovasc Magn Reson 2009; 11: 20.
27. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002; 360: 516-520. (Pubitemid 35232104)
28. Wood JC, Aguilar M, Otto-Duessel M, Nick H, Nelson MD, Moats R. Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med 2008; 60: 82-89. (Pubitemid 351956612)
29. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101: 4632-4639. (Pubitemid 36857840)
30. Di Tucci AA, Matta G, Deplano S, Gabbas A, Depau C, Derudas D et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008; 93: 1385-1388.
31. He T, Gatehouse PD, Kirk P, Tanner MA, Smith GC, Keegan J et al. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging 2007; 25: 1205-1209. (Pubitemid 46870279)
32. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008; 60: 1082-1089.
33. Leung AW, Chu WC, Lam WW, Lee V, Li CK. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatr Blood Cancer 2009; 53: 1054-1059.
34. Rose C, Ernst O, Hecquet B, Maboudou P, Renom P, Noel MP et al. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Haematologica 2007; 92: 850-853. (Pubitemid 350155314)
35. Cazzola M, Della Porta MG, Malcovati L. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2008; 2008: 166-175 (Review).
36. Salo S, Alanen A, Leino R, Bondestam S, Komu M. The effect of haemosiderosis and blood transfusions on the T2 relaxation time and 1/T2 relaxation rate of liver tissue. Br J Radiol 2002; 75: 24-27. (Pubitemid 34168317)